This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baege, A. C. Articles by Schlegel, R. Search for Related Content PubMed PubMed Citation Articles by Baege, A. C. Articles by Schlegel, R.

(American Journal of Pathology. 2002;160:1251-1257.)
© 2002 American Society for Investigative Pathology

Short Communication

Cervical Epithelial Cells Transduced with the Papillomavirus E6/E7 Oncogenes Maintain Stable Levels of Oncoprotein Expression but Exhibit Progressive, Major Increases in hTERT Gene Expression and Telomerase Activity

Astrid C. Baege^*, Allison Berger, Robert Schlegel, Tim Veldman^* and Richard Schlegel^*

From the Department of Pathology,^* Georgetown UniversityMedical Center, Washington, District of Columbia; and MillenniumPharmaceuticals, Incorporated,Cambridge, Massachusetts

Cervical carcinoma cells display high telomerase activity and usually contain and express integrated copies of the human papillomavirus (HPV) genome. Recent studies have demonstrated that the E6 oncogene of malignancy-associated HPVs increases cellular telomerase activity, predominantly via transcriptional activation of the catalytic subunit of telomerase, hTERT. To examine the relationship between E6 oncoprotein expression and telomerase expression during cellular immortalization, we transduced primary human cervical epithelial cells with the HPV E6/E7 genes and monitored temporal changes in viral oncoprotein expression, cellular hTERT RNA expression, and cellular telomerase activity. Quantitation of the individual E6 and E7 proteins, using a newly developed immunoprecipitation/immunoblotting technique, demonstrated that both oncoproteins were expressed at stable levels during successive passages of cervical cells. In contrast, the levels of hTERT mRNA and telomerase activity increased progressively and dramatically during passaging. Late-passage immortalized cells (passage 30) showed a 25-fold increase in hTERT mRNA and a 300-fold increase in telomerase activity compared to early-passage (passage 4) cells. Thus, neither hTERT mRNA expression nor telomerase activity are directly proportional to the level of E6 oncoprotein, indicating that E6 is not the sole determinant of the high levels of telomerase in cervical cells during immortalization.

This article has been cited by other articles:

				W. Deng, S. W. Tsao, Y. K. Kwok, E. Wong, X. R. Huang, S. Liu, C. M. Tsang, H. Y.S. Ngan, A. N.Y. Cheung, H. Y. Lan, et al. Transforming Growth Factor {beta}1 Promotes Chromosomal Instability in Human Papillomavirus 16 E6E7-Infected Cervical Epithelial Cells Cancer Res., September 1, 2008; 68(17): 7200 - 7209. [Abstract] [Full Text] [PDF]

				E. Krawczyk, F. A. Suprynowicz, X. Liu, Y. Dai, D. P. Hartmann, J. Hanover, and R. Schlegel Koilocytosis: A Cooperative Interaction between the Human Papillomavirus E5 and E6 Oncoproteins Am. J. Pathol., September 1, 2008; 173(3): 682 - 688. [Abstract] [Full Text] [PDF]

				X. Liu, G. L. Disbrow, H. Yuan, V. Tomaic, and R. Schlegel Myc and Human Papillomavirus Type 16 E7 Genes Cooperate To Immortalize Human Keratinocytes J. Virol., November 15, 2007; 81(22): 12689 - 12695. [Abstract] [Full Text] [PDF]

				G. L. Disbrow, A. C. Baege, K. A. Kierpiec, H. Yuan, J. A. Centeno, C. A. Thibodeaux, D. Hartmann, and R. Schlegel Dihydroartemisinin Is Cytotoxic to Papillomavirus-Expressing Epithelial Cells In vitro and In vivo Cancer Res., December 1, 2005; 65(23): 10854 - 10861. [Abstract] [Full Text] [PDF]

				X. Liu, H. Yuan, B. Fu, G. L. Disbrow, T. Apolinario, V. Tomaic, M. L. Kelley, C. C. Baker, J. Huibregtse, and R. Schlegel The E6AP Ubiquitin Ligase Is Required for Transactivation of the hTERT Promoter by the Human Papillomavirus E6 Oncoprotein J. Biol. Chem., March 18, 2005; 280(11): 10807 - 10816. [Abstract] [Full Text] [PDF]

				W. Chai, J. W. Shay, and W. E. Wright Human Telomeres Maintain Their Overhang Length at Senescence Mol. Cell. Biol., March 15, 2005; 25(6): 2158 - 2168. [Abstract] [Full Text] [PDF]

				L. Gewin, H. Myers, T. Kiyono, and D. A. Galloway Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex Genes & Dev., September 15, 2004; 18(18): 2269 - 2282. [Abstract] [Full Text] [PDF]

				A. C. Baege, G. L. Disbrow, and R. Schlegel IGFBP-3, a Marker of Cellular Senescence, Is Overexpressed in Human Papillomavirus-Immortalized Cervical Cells and Enhances IGF-1-Induced Mitogenesis J. Virol., June 1, 2004; 78(11): 5720 - 5727. [Abstract] [Full Text] [PDF]

				V. A. Shamanin and E. J. Androphy Immortalization of Human Mammary Epithelial Cells Is Associated with Inactivation of the p14ARF-p53 Pathway Mol. Cell. Biol., March 1, 2004; 24(5): 2144 - 2152. [Abstract] [Full Text] [PDF]

				B. Fu, J. Quintero, and C. C. Baker Keratinocyte Growth Conditions Modulate Telomerase Expression, Senescence, and Immortalization by Human Papillomavirus Type 16 E6 and E7 Oncogenes Cancer Res., November 15, 2003; 63(22): 7815 - 7824. [Abstract] [Full Text] [PDF]

				G. Borzacchiello, G. Iovane, M. L. Marcante, F. Poggiali, F. Roperto, S. Roperto, and A. Venuti Presence of bovine papillomavirus type 2 DNA and expression of the viral oncoprotein E5 in naturally occurring urinary bladder tumours in cows J. Gen. Virol., November 1, 2003; 84(11): 2921 - 2926. [Abstract] [Full Text] [PDF]

				I. Horikawa and J. C. Barrett Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms Carcinogenesis, July 1, 2003; 24(7): 1167 - 1176. [Abstract] [Full Text] [PDF]